Hoosiers age 80 and older turn out by the hundreds for COVID-19 shots
The Indiana Department of Health said more than 86,000 Hoosiers aged 80 or older had registered as of 4 p.m. Sunday for vaccinations.
John Russell
Articles
In midst of pandemic, drugmakers raise prices on hundreds of prescription drugs
So far this month, drugmakers have hiked prices on 636 drugs, according to research by GoodRx, which tracks prescription drug prices and offer a mobile app to help consumers find the lowest prices on hundreds of drugs.
Lilly shares surge after its potential Alzheimer’s drug slows cognitive decline
The experimental drug, donanemab, could be a huge breakthrough for Lilly, which has spent billions of dollars over 30 years researching treatments for Alzheimer’s disease, only to see them fall short in clinical trials.
Lilly’s COVID treatment sparks little demand
For a highly touted drug meant to keep throngs of people out of hospitals during a pandemic, Eli Lilly and Co.’s wonder treatment bamlanivimab sure has been slow to catch on.
State vaccine registration website slows under surge from Hoosiers
The Indiana Department of Health said Friday morning that the website and the alternate 2-1-1 phone registration system were working but urged Hoosiers to be patient if put into holding queues.
Indiana to make vaccines available to 80+ age group starting Friday
Hoosiers 80 and older account for 3.8% of the state’s population but more than 19% of hospitalizations and 52% of COVID-19 deaths.
How you can keep a close eye on vaccinations in Indiana
The state’s new dashboard on COVID-19 vaccines provides interesting breakdowns on who is getting vaccinated, by county, by gender, by race, by age and a host of other statistics sure to please any proud data geek.
State hopes stories of recovery reach Hoosiers who are addicted
A three-year educational and marketing effort in Indiana called “Know the Facts” aims to build interest through simple, understated messages on billboards, buses, broadcast commercials and social media.
Q&A: Here’s what we know now about COVID vaccines in Indiana
State health officials shared some new information and a few details during Gov. Eric Holcomb’s weekly press briefing on Wednesday.
IU Health forming ‘wide-ranging group’ of medical experts to review death of Black doctor
Vice President-elect Kamala Harris took up Dr. Moore’s cause on Tuesday, saying the complaints of Black women are “often downplаyed or ignored in our health care system.”
Indiana’s life sciences sector racks up annual record $257M in venture funding
The 39 companies that won venture funding represent a wide range of therapeutics, devices and health information technology.
Vaccines will be ‘scarce resource for a really long time,’ Indiana health officials say
Indiana received 55,000 doses of the Pfizer vaccine on Friday, and another 39,000 doses on Monday, which is a fraction of the state’s needs, officials say.
The shrinking Pfizer vaccine allotment: An Indiana mystery wrapped in a riddle
Last week, state health officials said they expected to initially receive 55,575 doses of Pfizer’s COVID-19 vaccine, and had already begun vaccinating front-line health care workers. But just five days later, state officials and hospitals are keeping mum about how many doses they actually received, except to say it was fewer than expected.
Lilly CEO urges hospitals to use COVID antibody treatments, after supplies pile up
Less than 20% of the monoclonal antibody doses shipped by two companies, Indianapolis-based Lilly and New York-based Regeneron, have have used, officials say, even though they can reduce hospitalizations by up to 70%.
Hospitals discharge patients early to free beds during pandemic
Hospitals are discharging patients several days earlier than they otherwise would, sending them home sometimes with oxygen machines, intravenous lines and powerful medicines.
Lilly starting new trial for COVID-19 antibody, potentially widening already red-hot market
Lilly said it will enroll up to 500,000 people in its latest study, with at least 5,000 people expected to receive bamlanivimab therapy. The drugmaker is partnering with health insurer UnitedHealth Group to see if the drug will help high-risk people.
No longer sleepy and small, Elanco marks transformation with new HQ
CEO Jeff Simmons said the company’s high-profile downtown Indianapolis headquarters will signal a cultural transformation at the company, which for most of its six decades of existence operated as a little-noticed subsidiary of Eli Lilly and Co.
Elanco to build $100 million HQ campus at former GM site downtown
The state has offered at least $86 million in tax incentives, plus land for the project.
Indiana gets ready for COVID vaccines, which officials expect within weeks
Two companies are awaiting emergency authorization to distribute vaccines in the United States, following Britain’s action Wednesday to become the first country in the world to approve a vaccine.
After years of decline, coal industry pushes back
Coal is rebranding itself from a dirty, low-tech fuel into a reliable source of energy. And it might have powerful friends in the Indiana General Assembly in that effort.